Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Constipation 1Colorectal Neoplasms 1Colorectal Cancer Screening 1Colonic Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
polyethylene glycol 3350 × Clear all
NCT07215000 2025-10-09

COOP SIT

Morehouse School of Medicine

Phase 4 Recruiting
300 enrolled
Gastrointestinal

Colorectal Cancer Screening

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

University of Iowa

Phase 4 Recruiting
240 enrolled
GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT01170754 2017-09-13

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Temple University

Phase 4 Completed
136 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms

NCT00626054 2016-04-13

PEG

Rabin Medical Center

Phase 4 Completed
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡